Eden Medical
Generated 5/10/2026
Executive Summary
Eden Medical is a San Francisco-based medical device and digital health company focused on non-invasive technologies for wound visualization and prevention, with a primary emphasis on diabetic foot ulcers. Founded in 2019, the company aims to improve diagnosis and monitoring by visualizing sub-surface wound conditions, addressing a critical gap in wound care management. Its product portfolio includes imaging systems and smart wearable devices designed for wound and ostomy care. Diabetic foot ulcers affect millions globally and are a leading cause of amputations, representing a large and underserved market. Eden Medical's technology has the potential to enable earlier detection, better treatment monitoring, and reduced healthcare costs. While the company is still in the early stages without disclosed funding or commercial products, its focus on a high-need area and innovative approach to non-invasive imaging position it for growth. The company's progress will depend on regulatory clearances, clinical validation, and commercialization efforts.
Upcoming Catalysts (preview)
- Q3 2026FDA 510(k) Clearance for Wound Imaging System70% success
- Q2 2026Pilot Clinical Study Results for Smart Wearable Device60% success
- Q4 2026Strategic Partnership with Major Wound Care Center Chain50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)